MTAP loss: a possible therapeutic approach for glioblastoma

Glioblastoma is the most lethal form of brain tumor with a recurrence rate of almost 90% and a survival time of only 15 months post-diagnosis. It is a highly heterogeneous, aggressive, and extensively studied tumor. Multiple studies have proposed therapeutic approaches to mitigate or improve the sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Patro, C. Pawan K., Biswas, Nupur, Pingle, Sandeep C., Lin, Feng, Anekoji, Misa, Jones, Lawrence D., Kesari, Santosh, Wang, Feng, Ashili, Shashaanka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791736/
https://www.ncbi.nlm.nih.gov/pubmed/36572880
http://dx.doi.org/10.1186/s12967-022-03823-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791736/
https://www.ncbi.nlm.nih.gov/pubmed/36572880
http://dx.doi.org/10.1186/s12967-022-03823-8

Ejemplares similares